Total Payments
$8,830
2023 Payments
$1,758
Companies
32
Transactions
359
Medicare Patients
3,517
Medicare Billing
$438,525
Payment Breakdown by Category
Food & Beverage$6,744 (76.4%)
Travel$2,032 (23.0%)
Education$54.00 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,744 | 352 | 76.4% |
| Travel and Lodging | $2,032 | 6 | 23.0% |
| Education | $54.00 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $3,257 | 28 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $778.92 | 63 | $0 (2023) |
| SI-BONE, INC. | $564.07 | 11 | $0 (2023) |
| Collegium Pharmaceutical, Inc. | $545.71 | 42 | $0 (2023) |
| Nevro Corp. | $476.92 | 17 | $0 (2023) |
| ABBVIE INC. | $471.62 | 33 | $0 (2023) |
| PROTEGA PHARMACEUTIALS INC | $325.80 | 7 | $0 (2023) |
| IDORSIA PHARMACEUTICALS US INC | $232.31 | 8 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $219.11 | 11 | $0 (2023) |
| BioDelivery Sciences International, Inc. | $215.97 | 36 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $1,758 | 96 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($286.32) |
| 2022 | $5,285 | 132 | Medtronic, Inc. ($3,141) |
| 2021 | $1,787 | 131 | BioDelivery Sciences International, Inc. ($215.97) |
All Payment Transactions
359 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/22/2023 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/06/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Gastroenterology | ||||||
| 12/01/2023 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/21/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $7.77 | General |
| Category: Opioid Analgesic | ||||||
| 11/21/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $3.48 | General |
| Category: PAIN | ||||||
| 11/18/2023 | Scilex Pharmaceuticals Inc. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: Analgesic | ||||||
| 11/15/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: NEUROSCIENCE | ||||||
| 11/10/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: PAIN | ||||||
| 11/08/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $16.88 | General |
| Category: Opioid Analgesic | ||||||
| 11/07/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: INSOMNIA | ||||||
| 11/02/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $12.05 | General |
| Category: Opioid Analgesic | ||||||
| 11/02/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $3.30 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Gastroenterology | ||||||
| 10/25/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $3.30 | General |
| Category: Gastroenterology | ||||||
| 10/25/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $0.51 | General |
| Category: Gastroenterology | ||||||
| 10/20/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.77 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: PAIN | ||||||
| 10/14/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $4.50 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $7.49 | General |
| Category: Opioid Analgesic | ||||||
| 10/04/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Gastroenterology | ||||||
| 10/04/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $17.29 | General |
| Category: Opioid Analgesic | ||||||
| 10/04/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.87 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $0.96 | General |
| Category: Gastroenterology | ||||||
| 09/20/2023 | SANOFI-AVENTIS U.S. LLC | SYNVISC-ONE (Device) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Orthopedics/Orthopedic Surgery | ||||||
| 09/15/2023 | Scilex Pharmaceuticals Inc. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 665 | 2,039 | $278,510 | $100,830 |
| 2022 | 6 | 789 | 2,270 | $333,435 | $124,070 |
| 2021 | 7 | 930 | 2,041 | $205,509 | $105,403 |
| 2020 | 8 | 1,133 | 2,460 | $234,974 | $108,222 |
Total Patients
3,517
Total Services
8,810
Medicare Billing
$438,525
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 252 | 812 | $162,400 | $52,724 | 32.5% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 239 | 668 | $80,160 | $38,408 | 47.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 70 | 128 | $15,360 | $5,624 | 36.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 42 | 69 | $13,125 | $2,814 | 21.4% |
| 99344 | Residence visit for new patient with moderate level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 11 | 11 | $2,200 | $1,012 | 46.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 51 | 351 | $5,265 | $247.28 | 4.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 266 | 837 | $167,400 | $56,374 | 33.7% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 270 | 793 | $95,040 | $46,186 | 48.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 158 | 291 | $35,070 | $12,101 | 34.5% |
| J7326 | Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | Office | 2022 | 11 | 14 | $21,000 | $6,539 | 31.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 45 | 60 | $10,800 | $2,642 | 24.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 39 | 275 | $4,125 | $227.04 | 5.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 306 | 796 | $121,050 | $56,130 | 46.4% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 252 | 463 | $37,800 | $28,537 | 75.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 243 | 388 | $39,200 | $17,976 | 45.9% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 29 | 40 | $5,450 | $1,715 | 31.5% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2021 | 45 | 50 | $1,050 | $630.00 | 60.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 40 | 283 | $478.50 | $263.60 | 55.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 15 | 21 | $480.00 | $152.49 | 31.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 372 | 922 | $124,054 | $52,770 | 42.5% |
| 80307 | Testing for presence of drug | Office | 2020 | 297 | 464 | $37,320 | $27,267 | 73.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 320 | 586 | $59,144 | $24,021 | 40.6% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 36 | 52 | $10,716 | $2,278 | 21.3% |
| 99358 | Prolonged patient service without direct patient contact first hour | Office | 2020 | 14 | 14 | $1,456 | $950.34 | 65.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2020 | 51 | 372 | $583.58 | $416.37 | 71.3% |
About Genesis Young
Genesis Young is a Family healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/23/2015. The National Provider Identifier (NPI) number assigned to this provider is 1760851422.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Genesis Young has received a total of $8,830 in payments from pharmaceutical and medical device companies, with $1,758 received in 2023. These payments were reported across 359 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($6,744).
As a Medicare-enrolled provider, Young has provided services to 3,517 Medicare beneficiaries, totaling 8,810 services with total Medicare billing of $438,525. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Louisville, KY
- Active Since 09/23/2015
- Last Updated 07/21/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1760851422
Products in Payments
- VANTA ADAPTIVESTIM (Device) $2,707
- RELISTOR (Drug) $778.92
- INTELLIS ADAPTIVESTIM (Device) $484.35
- NURTEC ODT (Drug) $482.02
- XTAMPZA (Drug) $396.22
- Omnia (Device) $324.20
- QULIPTA (Drug) $244.03
- QUVIVIQ (Drug) $232.31
- BELBUCA (Drug) $215.97
- AJOVY (Biological) $202.15
- ROXYBOND (Drug) $199.18
- UBRELVY (Drug) $194.31
- ZTLido (Drug) $162.16
- IFUSE IMPLANT (Device) $153.11
- Senza (Device) $152.72
- Movantik (Drug) $149.84
- Belbuca (Drug) $149.49
- Roxybond (Drug) $126.62
- Repatha (Biological) $125.00
- Qutenza (Drug) $109.39
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Louisville
Ruth Carrico, Rn, Msn, Phd, RN, MSN, PHD
Family — Payments: $403,371
Family $403,371
Ms. Smita Ranjan, Aprn, APRN
Family — Payments: $75,893
Family $75,893
Ashley Knable, Arnp, ARNP
Family — Payments: $75,423
Family $75,423
Danielle Revert, Aprn, APRN
Family — Payments: $64,469
Family $64,469
Mrs. Kassandra Green, Aprn, APRN
Family — Payments: $53,897
Family $53,897
Dr. Tracey Gaslin, Aprn, APRN
Family — Payments: $50,759
Family $50,759